Characterization of Amyloid Deposits in Neurodegenerative Diseases
The extracellular accumulation of insoluble fibrillar peptides in brain parenchyma and vessel walls as amyloid is the hallmark of neurodegenerative diseases, such as Alzheimer’s disease and Prion diseases. Regardless their amino acid sequences, all amyloid peptides adopt an insoluble, highly ordered beta sheet structure when aggregated. Amyloid is homogeneous and eosinophilic and, common to most cross-beta-type structures; it is generally identified by apple-green birefringence when stained with Congo red and seen under polarized light. Amyloid can also be identified by an apple green color when stained with thioflavine-S and seen under a fluorescence microscope. By electron microscopy, the typical fibrillar ultrastructure of amyloid deposits is revealed. The biochemical nature of the amyloid subunits present in the deposits can be recognized by immunohistochemistry using specific antibodies or by amino acid sequencing analysis, western blot, and mass spectrometry after isolation of parenchymal or vascular amyloid proteins.
- Imaging of Insulin Exocytosis from Pancreatic Beta Cells
- Approaches to the Stable Transfection of G Protein-Coupled Receptors
- cGMP-Immunocytochemistry
- Escalation of Drug Use
- Automated Patch Clamping
- Isolation and Properties of an In Vitro Human Outer Blood-Retinal Barrier Model
- Molecular Mechanisms of Opiate Addiction in the Nucleus Accumbens: Morphine Regulation of G Proteins
- Multiple Opioid Receptors in the Central Nervous System
- In Vivo Manipulation of Intracellular Signalling Pathways
- Neurogenic Astrocytes and Their Glycoconjugates: Not Just Glue Anymore